Spinal Tech

Anulex Technologies Raises $20M for Soft Tissue Repair Product Development

Anulex Technologies has announced the first closing of its fifth round of private equity financing which will total a minimum of $20 million, according to a press release.

Staff

Friday, June 4th, 2010

The Series E round of financing, which will have raised about $68.6 million upon completion, will go to the company’s development of soft tissue repair products.

Anulex’s CEO said the money would go toward the company’s Xclose Tissue Repair System and its Rimclose product.

Learn more about the new financing for Anulex Technologies.

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

AI in spine care has been commonly leveraged to support administrative tasks, but one of its real potentials lies in…

By: Carly Behm
Wednesday, November 19th, 2025
Stryker net sales up 10.3% in Q3: 5 notes

Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.…

By: Ariana Portalatin
Friday, October 31st, 2025
4 spine FDA nods in October

Here are four companies earning FDA clearance for spine technology this month: 1. Elevation Spine’s Saber-C earned FDA clearance for…

By: Ariana Portalatin
Friday, October 31st, 2025

Comments are closed.

From daily engagement to year-round gains: Turning RPM and PERS data into quality wins

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

Stryker net sales up 10.3% in Q3: 5 notes

4 spine FDA nods in October

Join the spine leaders & surgeons who start their day with Becker's